As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: December 7, 2013
by Nigel Atkins for Mirror:
A test has been developed which can predict the onset of Alzheimer’s two years earlier than previously.
And a team at the University of Montreal, Canada, said it was 90% accurate.
Currently the disease is often diagnosed late in its development and sometimes up to ten years after the first pathological changes have affected the brain.
A challenge for doctors has been to provide earlier diagnosis so that patients can receive treatment as early as possible.
Prof Sylvie Belleville said: “When used individually, neuroimaging and neuropsychology are effective but only up to a certain point.
“It is when combining and analysing the results from both methods that we could achieve such an exceptional level of accuracy.
“For the moment, we can’t diagnose this disease very early due to the lack of reliable protocols. Thus, there is a risk of erronously identifying the disease when trying to diagnose it too early.
“The innovation here is showing that two different approaches can be combined to aid in diagnosis.
“The clinical benefits of these extra two years are enormous.
“We can now evaluate the effectiveness of pharmacological and non-pharmacological therapies on the outcome of a clinical diagnosis of Alzheimer’s disease in people identified with these tools.
“We could assess whether these treatments are more effective when administered earlier.”
The study was published in the Journal of Alzheimer’s Disease.
Thirty-six million people worldwide suffer from Alzheimer’s disease and dementia. In Canada, 25,000 new cases are diagnosed each year. Those sobering numbers have researchers around the globe racing to come up with new ways to...
he Food and Drug Administration issued new guides on drug development for neurological disorders. This sets the stage for possible treatments for Alzheimer’s. The disease-oriented development guide documents will provide details on how researchers...
For young adults with autosomal dominant Alzheimer’s disease (AD), molecular markers can identify changes associated with the disease before clinical onset, according to a study published online Feb. 12 in JAMA Neurology. Yakeel T. Quiroz, Ph.D., from Massachusetts...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.